Scholarlink

Background <p>Maple syrup urine disease (MSUD) is a rare inherited metabolic disorder caused by a deficiency in the branched-chain alpha-keto acid dehydrogenase complex, leading to the accumulation of branched-chain amino acids. This case series describes the clinical and genetic findings of ten Iranian patients with MSUD, focusing on novel mutations in the BCKDHA, BCKDHB, and DBT genes.</p> Methods and results <p>Ten unrelated patients, all from consanguineous marriages, were diagnosed with MSUD based on clinical presentations and metabolite levels. Whole exome sequencing (WES) and Sanger sequencing identified five novel mutations (c.776&#xa0;C &gt; T, IVS5-1G &gt; C, c.1070&#xa0;C &gt; T, c.807-813del7nt, c.772-773insT) and two previously reported mutations in these patients. Pathogenicity was assessed using bioinformatics tools and confirmed by their absence in healthy controls.</p> Conclusions <p>This case series highlights the genetic heterogeneity of MSUD in the Iranian population, identifying novel mutations associated with severe clinical presentations. These findings emphasize the value of genetic testing for early diagnosis and genetic counseling in consanguineous populations, with implications for managing MSUD and preventing complications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genetic variability in maple syrup urine disease: novel mutations and their pathogenicity in the Iranian population

  • 期刊论文

  • 发表日期：

    2025年12月11日

查看全文
  • Mansooreh Jafari,
  • Fatemeh Karami,
  • Iman Salahshourifar,
  • Aria Setoodeh,
  • Ali Rahmanifar,
  • Hamideh Bagherian,
  • Mohammad Reza Alaei,
  • Farzaneh Rohani,
  • Sirous Zeinali

摘要

Background

Maple syrup urine disease (MSUD) is a rare inherited metabolic disorder caused by a deficiency in the branched-chain alpha-keto acid dehydrogenase complex, leading to the accumulation of branched-chain amino acids. This case series describes the clinical and genetic findings of ten Iranian patients with MSUD, focusing on novel mutations in the BCKDHA, BCKDHB, and DBT genes.

Methods and results

Ten unrelated patients, all from consanguineous marriages, were diagnosed with MSUD based on clinical presentations and metabolite levels. Whole exome sequencing (WES) and Sanger sequencing identified five novel mutations (c.776 C > T, IVS5-1G > C, c.1070 C > T, c.807-813del7nt, c.772-773insT) and two previously reported mutations in these patients. Pathogenicity was assessed using bioinformatics tools and confirmed by their absence in healthy controls.

Conclusions

This case series highlights the genetic heterogeneity of MSUD in the Iranian population, identifying novel mutations associated with severe clinical presentations. These findings emphasize the value of genetic testing for early diagnosis and genetic counseling in consanguineous populations, with implications for managing MSUD and preventing complications.